Innovation in treating obsessive-compulsive disorder will not solve the care gap
Posted:
Obsessive-compulsive disorder (OCD) remains one of psychiatry’s most disabling conditions, affecting about 1-2% of the population. People with OCD have an 82% increase in all cause mortality compared with unnafected matched people from the general population, with suicide being a major contributor.
GIANT Health is delighted to welcome XR Therapeutics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase how immersive technology is helping transform mental health care across the NHS.
Mental health services…
GIANT Health is pleased to welcome Psyomics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase their innovative approach to improving mental health services through better information, earlier understanding and more informed…